Citations (79)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Colin Tuft, Elie Matar, Zoe Menczel Schrire, Ronald R Grunstein, Brendon J Yee & Camilla M Hoyos. (2023) Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults. Clinical Interventions in Aging 18, pages 49-59.
Read now
Read now
Jonathan G. Mun, Dan Wang, Denise L. Doerflein Fulk, Mina Fakhary, Scott J. Gualco, Ryan W. Grant & Susan Hazels Mitmesser. (2023) A Randomized, Double-Blind, Crossover Study to Investigate the Pharmacokinetics of Extended-Release Melatonin Compared to Immediate-Release Melatonin in Healthy Adults. Journal of Dietary Supplements 0:0, pages 1-13.
Read now
Read now
David J. Kennaway. (2022) What do we really know about the safety and efficacy of melatonin for sleep disorders?. Current Medical Research and Opinion 38:2, pages 211-227.
Read now
Read now
Natalia Kurhaluk. (2021) Alcohol and melatonin. Chronobiology International 38:6, pages 785-800.
Read now
Read now
P. Proserpio, S. Marra, C. Campana, E. C. Agostoni, L. Palagini, L. Nobili & R. E. Nappi. (2020) Insomnia and menopause: a narrative review on mechanisms and treatments. Climacteric 23:6, pages 539-549.
Read now
Read now
Natalia Kurhaluk & Halyna Tkachenko. (2020) Melatonin and alcohol-related disorders. Chronobiology International 37:6, pages 781-803.
Read now
Read now
Nava Zisapel. (2015) Current Phase II investigational therapies for insomnia. Expert Opinion on Investigational Drugs 24:3, pages 401-411.
Read now
Read now
Alan G Wade, Mildred Farmer, Gil Harari, Naama Fund, Moshe Laudon, Tali Nir, Anat Frydman-Marom & Nava Zisapel. (2014) Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer’s disease: a 6-month, randomized, placebo-controlled, multicenter trial. Clinical Interventions in Aging 9, pages 947-961.
Read now
Read now
Ludovit Paulis, Fedor Simko & Moshe Laudon. (2012) Cardiovascular effects of melatonin receptor agonists. Expert Opinion on Investigational Drugs 21:11, pages 1661-1678.
Read now
Read now
Patrick Lemoine & Nava Zisapel. (2012)
Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia. Expert Opinion on Pharmacotherapy 13:6, pages 895-905.
Read now
Read now
Patrick Lemoine, Doron Garfinkel, Moshe Laudon, Tali Nir & Nava Zisapel. (2011) Prolonged-release melatonin for insomnia – an open-label long-term study of efficacy, safety, and withdrawal. Therapeutics and Clinical Risk Management 7, pages 301-311.
Read now
Read now
Doron Garfinkel, Mariana Zorin, Julio Wainstein, Zipora Matas, Moshe Laudon & Nava Zisapel. (2011) Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study. Diabetes, Metabolic Syndrome and Obesity 4, pages 307-313.
Read now
Read now
Articles from other publishers (67)
Julia Maruani, Eve Reynaud, Juliette Chambe, Laura Palagini, Patrice Bourgin & Pierre A. Geoffroy. (2023)
Efficacy of melatonin and ramelteon for the acute and long‐term management of insomnia disorder in adults: A systematic review and
meta‐analysis
. Journal of Sleep Research 32:6.
Crossref
Crossref
Young-Min Park, So-Jin Lee, Jin-Seong Lee, Kyoung-Sae Na, Seung-Gul Kang, Bun-Hee Lee, Ho-Kyoung Yoon & Eui-Joong Kim. (2023) Efficacy and Safety of Prolonged-Release Melatonin for Primary Insomnia in Elderly Patients. Chronobiology in Medicine 5:3, pages 138-143.
Crossref
Crossref
Samira Ait Abdellah, Véronique Raverot, Caroline Gal, Isabelle Guinobert, Valérie Bardot, Claude Blondeau & Bruno Claustrat. (2023) Bioavailability of Melatonin after Administration of an Oral Prolonged-Release Tablet and an Immediate-Release Sublingual Spray in Healthy Male Volunteers. Drugs in R&D 23:3, pages 257-265.
Crossref
Crossref
Stefan Grenzer. (2023) „Haben Sie in letzter Zeit gut geschlafen?“. Geriatrie up2date 05:03, pages 225-242.
Crossref
Crossref
Bei Pan, Long Ge, Honghao Lai, Liangying Hou, Chen Tian, Qi Wang, Kelu Yang, Yao Lu, Hongfei Zhu, Mengting Li, Deren Wang, Xiuxia Li, Yuqing Zhang, Ya Gao, Ming Liu, Guowu Ding, Jinhui Tian & Kehu Yang. (2023) The Comparative Effectiveness and Safety of Insomnia Drugs: A Systematic Review and Network Meta-Analysis of 153 Randomized Trials. Drugs 83:7, pages 587-619.
Crossref
Crossref
Francy Cruz-Sanabria, Claudia Carmassi, Simone Bruno, Andrea Bazzani, Marco Carli, Marco Scarselli & Ugo Faraguna. (2023) Melatonin as a Chronobiotic with Sleep-promoting Properties. Current Neuropharmacology 21:4, pages 951-987.
Crossref
Crossref
Zixuan Xu, Wen Li, Yixin Sun, Wen Jin, Li Yu, Jingyuan Yang & Qi Wang. (2023) Melatonin alleviates PTSD-like behaviors and restores serum GABA and cortisol levels in mice. Psychopharmacology 240:2, pages 259-269.
Crossref
Crossref
Pichai Leerasiri, Pimchanok Pariyaeksut, Pattaya Hengrasmee & Chutimon Asumpinwong. (2022) Effectiveness of melatonin for the treatment of nocturia: a randomized controlled trial. International Urogynecology Journal 34:2, pages 485-492.
Crossref
Crossref
E.V. Verbitsky & M.G. Poluektov. (2023) Sleep regulation as a complex process. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 123:5, pages 8.
Crossref
Crossref
Adam Z. Levitan, Ervis Musa & Colin M. Shapiro. 2023. Encyclopedia of Sleep and Circadian Rhythms. Encyclopedia of Sleep and Circadian Rhythms
381
391
.
Mirko Petrovic. 2023. Optimizing Pharmacotherapy in Older Patients. Optimizing Pharmacotherapy in Older Patients
391
404
.
Kyungseon Choi, Yu Jeong Lee, Seonyoung Park, Nam Kyung Je & Hae Sun Suh. (2022) Efficacy of melatonin for chronic insomnia: Systematic reviews and meta-analyses. Sleep Medicine Reviews 66, pages 101692.
Crossref
Crossref
Matthew Salanitro, Torsten Wrigley, Hisham Ghabra, Edward de Haan, Catherine M. Hill, Marco Solmi & Samuele Cortese. (2022) Efficacy on sleep parameters and tolerability of melatonin in individuals with sleep or mental disorders: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews 139, pages 104723.
Crossref
Crossref
Hyung Ki Kim & Kwang Ik Yang. (2022) Melatonin and melatonergic drugs in sleep disorders. Translational and Clinical Pharmacology 30:4, pages 163.
Crossref
Crossref
Gholami Fatemeh, Moradi Sajjad, Rasaei Niloufar, Soveid Neda, Setayesh Leila & Mirzaei Khadijeh. (2021) Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trials. Journal of Neurology 269:1, pages 205-216.
Crossref
Crossref
Adam Wichniak, Aleksander Kania, Mariusz Siemiński & Wiesław Jerzy Cubała. (2021) Melatonin as a Potential Adjuvant Treatment for COVID-19 beyond Sleep Disorders. International Journal of Molecular Sciences 22:16, pages 8623.
Crossref
Crossref
Natalie A. Grima, Shantha M.W. Rajaratnam, Darren Mansfield, Dean McKenzie & Jennie L. Ponsford. (2021) Poorer sleep quality predicts melatonin response in patients with traumatic brain injury: findings from a randomized controlled trial. Journal of Clinical Sleep Medicine 17:8, pages 1545-1551.
Crossref
Crossref
Dewan Md. Sumsuzzman, Jeonghyun Choi, Yunho Jin & Yonggeun Hong. (2021) Neurocognitive effects of melatonin treatment in healthy adults and individuals with Alzheimer’s disease and insomnia: A systematic review and meta-analysis of randomized controlled trials. Neuroscience & Biobehavioral Reviews 127, pages 459-473.
Crossref
Crossref
Ahmet Yardimci, Mehmet Ridvan Ozdede & Haluk Kelestimur. (2021) Agomelatine, A Potential Multi-Target Treatment Alternative for Insomnia, Depression, and Osteoporosis in Postmenopausal Women: A Hypothetical Model. Frontiers in Psychiatry 12.
Crossref
Crossref
Irene Moroni, Alfonso Garcia-Bennett, Julia Chapman, Ronald R. Grunstein, Christopher J. Gordon & Maria Comas. (2021) Pharmacokinetics of exogenous melatonin in relation to formulation, and effects on sleep: A systematic review. Sleep Medicine Reviews 57, pages 101431.
Crossref
Crossref
M.F. Vecchierini, U. Kilic-Huck & M.A. Quera-Salva. (2021) La mélatonine (MEL) et son utilisation dans les pathologies neurologiques et l’insomnie : recommandations de la Société française de recherche et de médecine du sommeil (SFRMS). Médecine du Sommeil 18:2, pages 70-89.
Crossref
Crossref
Jagruti Thoke, Shivangi Patel & Anuradha Majumdar. (2021) Understanding Skin Chronobiology to Unveil and Transform Dermal Chronotherapeutics: Paving the Way for the Future. Chronobiology in Medicine 3:1, pages 8-15.
Crossref
Crossref
M.F. Vecchierini, U. Kilic-Huck & M.A. Quera-Salva. (2021) Melatonin (MEL) and its use in neurological diseases and insomnia: Recommendations of the French Medical and Research Sleep Society (SFRMS). Revue Neurologique 177:3, pages 245-259.
Crossref
Crossref
Beth A. Malow, Robert L. Findling, Carmen M. Schroder, Athanasios Maras, John Breddy, Tali Nir, Nava Zisapel & Paul Gringras. (2021) Sleep, Growth, and Puberty After 2 Years of Prolonged-Release Melatonin in Children With Autism Spectrum Disorder. Journal of the American Academy of Child & Adolescent Psychiatry 60:2, pages 252-261.e3.
Crossref
Crossref
M.G. Poluektov. (2021) The use of psychotropic medications for chronic insomnia in clinical practice. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 121:4, pages 61.
Crossref
Crossref
Daniel L. KrinskyCydney E. McQueen & Katherine Kelly Orr. 2020. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 20th Edition. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 20th Edition.
J. Vanderlinden, F. Boen & J. G. Z. van Uffelen. (2020) Effects of physical activity programs on sleep outcomes in older adults: a systematic review. International Journal of Behavioral Nutrition and Physical Activity 17:1.
Crossref
Crossref
Kalliopi Vallianatou. (2020) Benzodiazepines and hypnotics. Medicine 48:12, pages 818-820.
Crossref
Crossref
B. Claustrat. (2020) Mélatonine : aspects biochimiques, physiologiques et pharmacologiques en relation avec les phénomènes rythmiques et le sommeil. Médecine du Sommeil 17:3, pages 177-194.
Crossref
Crossref
. (2020) Natürlichen Takt der inneren Uhr herstellen. psychopraxis. neuropraxis 23:1, pages 6-8.
Crossref
Crossref
Trevor Simper, Molly Gilmartin, Daniel Allwood, Luke Taylor & Andrew Chappell. (2019) The effects of a sleep/recovery supplement: ‘Night Time Recharge’ on sleep parameters in young adults. Nutrition and Health 25:4, pages 265-274.
Crossref
Crossref
Sue Wilson, Kirstie Anderson, David Baldwin, Derk-Jan Dijk, Audrey Espie, Colin Espie, Paul Gringras, Andrew Krystal, David Nutt, Hugh Selsick & Ann Sharpley. (2019) British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update. Journal of Psychopharmacology 33:8, pages 923-947.
Crossref
Crossref
Susan Smith, Brittany Vickery, Samir Kouzi & Kishan Patel. (2019) Melatonin use in an inpatient academic medical center: Factors affecting provider documentation of patients’ sleep quality. Journal of the American Pharmacists Association 59:4, pages 533-538.
Crossref
Crossref
Charles M. Morin, Simon Beaulieu-Bonneau & Janet M.Y. Cheung. 2019. Handbook of Sleep Disorders in Medical Conditions. Handbook of Sleep Disorders in Medical Conditions
27
50
.
Daniel E. Vigo & Daniel P. Cardinali. 2019. Psychiatry and Neuroscience Update. Psychiatry and Neuroscience Update
427
451
.
Andrea Lawson, Roohie Parmar & Eileen P. Sloan. 2019. Perinatal Psychopharmacology. Perinatal Psychopharmacology
341
376
.
Natalie A. Grima, Shantha M. W. Rajaratnam, Darren Mansfield, Tracey L. Sletten, Gershon Spitz & Jennie L. Ponsford. (2018) Efficacy of melatonin for sleep disturbance following traumatic brain injury: a randomised controlled trial. BMC Medicine 16:1.
Crossref
Crossref
Athanasios MarasCarmen M. SchroderBeth A. MalowRobert L. FindlingJohn BreddyTali NirShiri ShahmoonNava ZisapelPaul Gringras. (2018) Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology 28:10, pages 699-710.
Crossref
Crossref
Paola Proserpio, Dario Arnaldi, Flavio Nobili & Lino Nobili. (2018) Integrating Sleep and Alzheimer’s Disease Pathophysiology: Hints for Sleep Disorders Management. Journal of Alzheimer's Disease 63:3, pages 871-886.
Crossref
Crossref
Christopher J. Hodges, Rowan P. Ogeil & Dan I. Lubman. (2018) The effects of acute alcohol withdrawal on sleep. Human Psychopharmacology: Clinical and Experimental 33:3, pages e2657.
Crossref
Crossref
Daniel L. Krinsky, Stefanie P. Ferreri, Brian Hemstreet, Anne L. Hume, Gail D. Newton, Carol J. Rollins & Karen J. TietzeCydney E. McQueen & Katherine Kelly Orr. 2017. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 19th Edition. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 19th Edition.
Paul Gringras, Tali Nir, John Breddy, Anat Frydman-Marom & Robert L. Findling. (2017) Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder. Journal of the American Academy of Child & Adolescent Psychiatry 56:11, pages 948-957.e4.
Crossref
Crossref
Fiona Auld, Emily L. Maschauer, Ian Morrison, Debra J. Skene & Renata L. Riha. (2017) Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders. Sleep Medicine Reviews 34, pages 10-22.
Crossref
Crossref
Wenjing Zhang, Pengfei Jiang, Jin Chen, Chaonan Zhu, Zhengwei Mao & Changyou Gao. (2017) Application of melatonin-loaded poly(N-isopropylacrylamide) hydrogel particles to reduce the toxicity of airborne pollutes to RAW264.7 cells. Journal of Colloid and Interface Science 490, pages 181-189.
Crossref
Crossref
Mohammad Reza Rezvanfar, Gila Heshmati, Ali Chehrei, Farshid Haghverdi, Fatemeh Rafiee & Faezeh Rezvanfar. (2016) Effect of bedtime melatonin consumption on diabetes control and lipid profile. International Journal of Diabetes in Developing Countries 37:1, pages 74-77.
Crossref
Crossref
Yu Yong Shin, Jung-Ick Byun, Sung-Eun Chung, Min-Ji Seong, Han-Ah Cho, Hyun Keuk Cha & Won Chul Shin. (2016) Effect of Low and High-Dose GABA from Unpolished Rice-Germ on Timing and Quality of Sleep: A Randomized Double-Blind Placebo-Controlled Trial. Journal of Sleep Medicine 13:2, pages 60-66.
Crossref
Crossref
Rui Miguel Costa & Ivone dos Santos Martins. (2016) Melatonina na insônia primária: Quais as evidências?. Revista Brasileira de Medicina de Família e Comunidade 11:38, pages 1-9.
Crossref
Crossref
Helen Slawik, Michael Stoffel, Lina Riedl, Zdenko Veselý, Michael Behr, Jens Lehmberg, Corina Pohl, Bernhard Meyer, Michael Wiegand & Sandro M. Krieg. (2015) Prospective Study on Salivary Evening Melatonin and Sleep before and after Pinealectomy in Humans. Journal of Biological Rhythms 31:1, pages 82-93.
Crossref
Crossref
Klaus Wahle. (2015) Retardiertes Melatonin in der Behandlung der primären InsomnieProlonged-release melatonin for the treatment of primary insomnia. Review. MMW - Fortschritte der Medizin 157:S7, pages 14-18.
Crossref
Crossref
Emma L Arbon, Malgorzata Knurowska & Derk-Jan Dijk. (2015) Randomised clinical trial of the effects of prolonged-release melatonin, temazepam and zolpidem on slow-wave activity during sleep in healthy people. Journal of Psychopharmacology 29:7, pages 764-776.
Crossref
Crossref
Jaime M. Monti. 2015. Sleep Medicine. Sleep Medicine
527
532
.
Rebecca B Costello, Cynthia V Lentino, Courtney C Boyd, Meghan L O’Connell, Cindy C Crawford, Meredith L Sprengel & Patricia A Deuster. (2014) The effectiveness of melatonin for promoting healthy sleep: a rapid evidence assessment of the literature. Nutrition Journal 13:1.
Crossref
Crossref
Moshe Laudon & Anat Frydman-Marom. (2014) Therapeutic Effects of Melatonin Receptor Agonists on Sleep and Comorbid Disorders. International Journal of Molecular Sciences 15:9, pages 15924-15950.
Crossref
Crossref
Barbara W. Carlson & Mary H. Palmer. (2014) Nocturia in Older Adults. Nursing Clinics of North America 49:2, pages 233-250.
Crossref
Crossref
Malcolm Lader. (2014) Benzodiazepine harm: how can it be reduced?. British Journal of Clinical Pharmacology 77:2, pages 295-301.
Crossref
Crossref
Venkataramanujam Srinivasan, Rahimah Zakaria, Timo Partonen, Edward C. Lauterbach, Preetha Sharone Kuppuswamy, Amnon Brzezinski, Zahiruddin Othman & Atul Prasad. 2014. Melatonin and Melatonergic Drugs in Clinical Practice. Melatonin and Melatonergic Drugs in Clinical Practice
343
352
.
Katherine A. Dudley & Sanjay R. Patel. 2014. Impact of Sleep and Sleep Disturbances on Obesity and Cancer. Impact of Sleep and Sleep Disturbances on Obesity and Cancer
51
76
.
Eduardo Ferracioli-Oda, Ahmad Qawasmi & Michael H. Bloch. (2013) Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders. PLoS ONE 8:5, pages e63773.
Crossref
Crossref
Katherine A. Lyseng-Williamson. (2013) Melatonin prolonged release: a guide to its use in the treatment of insomnia in patients aged ≥55 years. Drugs & Therapy Perspectives 29:5, pages 125-129.
Crossref
Crossref
Mehmet E. Dokucu. 2013. Sleep Disorders in Women. Sleep Disorders in Women
121
134
.
Katherine A. Lyseng-Williamson. (2012) Melatonin Prolonged Release. Drugs & Aging 29:11, pages 911-923.
Crossref
Crossref
Ebru Ucar, Emilia K Lehtinen, Birte Y Glenthøj & Bob Oranje. (2012) The effect of acute exogenous melatonin on P50 suppression in healthy male volunteers stratified for low and high gating levels. Journal of Psychopharmacology 26:8, pages 1113-1118.
Crossref
Crossref
Sergio Domínguez-López, Ian Mahar, Francis Rodriguez Bambico, Benoit Labonté, Rafael Ochoa-Sánchez, Marco Leyton & Gabriella Gobbi. (2011) Short-term effects of melatonin and pinealectomy on serotonergic neuronal activity across the light–dark cycle. Journal of Psychopharmacology 26:6, pages 830-844.
Crossref
Crossref
Daniel P. Cardinali, Venkataramanujan Srinivasan, Amnon Brzezinski & Gregory M. Brown. (2012) Melatonin and its analogs in insomnia and depression. Journal of Pineal Research 52:4, pages 365-375.
Crossref
Crossref
Nico J. Diederich & Deborah J. McIntyre. (2012) Sleep disorders in Parkinson's disease: Many causes, few therapeutic options. Journal of the Neurological Sciences 314:1-2, pages 12-19.
Crossref
Crossref
M.A. Quera SalvaS. Hartley. (2012) Mood Disorders, Circadian Rhythms, Melatonin and Melatonin Agonists. Journal of Central Nervous System Disease 4, pages JCNSD.S4103.
Crossref
Crossref
. (2011) Insomnio en el anciano. FMC - Formación Médica Continuada en Atención Primaria 18, pages 33-48.
Crossref
Crossref